Autres langues Cytek Biosciences, Inc.

Actions

CTKB

US23285D1090

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 01/05/2024			Varia. 5j.	Varia. 1 janv.
6,37 ^USD	+5,99%		+12,54%	-30,15%

20/03	Un initié de Cytek Biosciences a vendu des actions d'une valeur de 269 600 $, selon un récent dépôt auprès de la SEC	MT
19/03	Cytek Biosciences nomme William McCombe au poste de directeur financier et réaffirme ses prévisions pour 2024	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe	30/04
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024	29/04
Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing	20/03
Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance	19/03
Cytek® Biosciences Names William McCombe Chief Financial Officer	19/03
Cytek® Biosciences Names William McCombe Chief Financial Officer	19/03
Cytek Biosciences, Inc. Announces Appointment of Patrik Jeanmonod as Head of Corporate Development Analytics	19/03
Cytek Biosciences, Inc. Announces CFO Changes	19/03
Cytek Biosciences Unveils New Manufacturing Facility in Wuxi, China	08/03
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions	07/03
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions	07/03
Cytek Biosciences, Inc. Opens A New 50,000-Square-Foot Facility in Wuxi, China	07/03
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on May 19, 2023.	01/03
Cytek Biosciences, Inc. Provides Earnings Guidance for the Year Ended December 31, 2024	01/03
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook	28/02
Cytek Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Cytek Biosciences to Participate in Upcoming Investor Conferences	07/02
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	07/02
Cytek Biosciences Agrees to Flow Cytometry Collaboration With Centre for Genomic Regulation, Pompeu Fabra University	18/01
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries	17/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cytek Biosciences, Inc.

Actions

CTKB

US23285D1090

Autres langues

Filtres